The Research Team

Kyle T. Greenway, M.D., M.Sc., FRCPC

Principal Investigator — McGill University

Dr. Greenway is an Assistant Professor in the Department of Psychiatry at McGill University, an attending psychiatrist at the Jewish General Hospital in Montreal, and an investigator at the Lady Davis Institute for Medical Research. He co-directs the Psychedelics and Contemplation research lab.

His research spans clinical, naturalistic, and fundamental studies of psychedelic-assisted therapies, with particular attention to the extra-pharmacological factors — set, setting, culture, and care context — that shape treatment outcomes.

McGill profile · Lady Davis Institute profile

Sara de la Salle, Ph.D.

Co-Investigator — McGill University

Dr. de la Salle is a Postdoctoral Fellow in the Department of Psychiatry at McGill University, supervised by Dr. Kyle Greenway. Her research focuses on psilocybin-assisted psychotherapy, with an emphasis on how individual differences and treatment preferences shape therapeutic outcomes.

She is currently leading Quebec’s first clinical trial of psilocybin-assisted therapy, examining the role of mindset, setting, and cultural context in informing more personalized approaches to care. Her work aims to advance rigorous, evidence-based practices in psychedelic-assisted treatment.

Elisabeth Irvine, B.Sc.

Co-Investigator — McGill University

Ms. Irvine is a MSc student in the Mental Health program at McGill University, supervised by Dr. Kyle Greenway.

She has experience coordinating research in both social and clinical psychology labs at McGill and is interested in understanding how social and contextual factors contribute to successful outcomes in psychedelic-assisted therapy.

Alexandre Lehmann, Ph.D.

Co-Investigator — McGill University

Dr. Lehmann is an Assistant Professor in the Department of Otolaryngology–Head and Neck Surgery at McGill University and Principal Investigator at the Centre for Research on Brain, Language and Music (CRBLM).

He has been involved in psychedelic science for over two decades, contributing to research, strategy, and stakeholder engagement across clinical, academic, and nonprofit sectors. His work is guided by an interest in the intersections of brain plasticity, music, and non-ordinary states.